Sequana Medical Cash Flow From Operations vs. Book Value Per Share

SEQUA Stock   0.78  0.01  1.27%   
Taking into consideration Sequana Medical's profitability measurements, Sequana Medical NV may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Sequana Medical's ability to earn profits and add value for shareholders.
For Sequana Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sequana Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sequana Medical NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sequana Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sequana Medical NV over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between Sequana Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sequana Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sequana Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sequana Medical NV Book Value Per Share vs. Cash Flow From Operations Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Sequana Medical's current stock value. Our valuation model uses many indicators to compare Sequana Medical value to that of its competitors to determine the firm's financial worth.
Sequana Medical NV is currently regarded as top stock in cash flow from operations category among its peers. It also is currently regarded as top stock in book value per share category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sequana Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sequana Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Sequana Book Value Per Share vs. Cash Flow From Operations

Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Sequana Medical

Operating Cash Flow

 = 

EBITDA

-

Taxes

 = 
(23.62 M)
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Sequana Medical

Book Value per Share

 = 

Common Equity

Average Shares

 = 
0.55 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

Sequana Book Value Per Share Comparison

Sequana Medical is currently under evaluation in book value per share category among its peers.

Sequana Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Sequana Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sequana Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sequana Medical's important profitability drivers and their relationship over time.

Use Sequana Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sequana Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sequana Medical will appreciate offsetting losses from the drop in the long position's value.

Sequana Medical Pair Trading

Sequana Medical NV Pair Trading Analysis

The ability to find closely correlated positions to Sequana Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sequana Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sequana Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sequana Medical NV to buy it.
The correlation of Sequana Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sequana Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sequana Medical NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sequana Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Sequana Medical position

In addition to having Sequana Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Precious Metals ETFs Thematic Idea Now

Precious Metals ETFs
Precious Metals ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Precious Metals ETFs theme has 28 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Sequana Stock

To fully project Sequana Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sequana Medical NV at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sequana Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Sequana Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Sequana Medical investors may work on each financial statement separately, they are all related. The changes in Sequana Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sequana Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.